Last update :
08/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anticancer drug   Bleomycin sulfate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Bileco Argentina
Blemisin Turkey
Blenamax Australia, Colombia, Malaysia
Blenoxane Australia, United States of America
Bleo-Kyowa Great Britain
Bleocell Germany
Bleocin Greece, Hungary, Japan, Malaysia, Peru, Poland, Portugal, Saudi Arabia, Turkey, United Arab Emirates
Bleocip Egypt, Venezuela
Bleocris Argentina, Chile, Peru
Bleolem Colombia, Mexico
Bleomax Mexico
Bleomedac Germany
Bleomicina Chile, Colombia, Ecuador, Italy, Mexico, Peru, Spain
Bleomycin Australia, Austria, Denmark, Finland, Germany, Great Britain, Hungary, Iceland, Iran, Netherlands, Norway, Poland, Romania, Sweden, United States of America
Bleomycine Belgium, Canada, France, Ireland, Luxembourg, Malaysia, Morocco, New Zealand, Switzerland, Tunisia
Bleomycine A Denmark
Bleomycinum Germany
Bleozen Peru
Blexit Chile
Blocamicina Argentina
Bloicin Egypt, Peru
Blomindex Mexico
Blucin Morocco
DBL Bleomycin Malaysia, New Zealand
Ifabec Mexico
Lyoble Peru
Nikableocina Chile
Oncobleocin Colombia
Stability of mixtures   Injection   Stability of mixtures : Bleomycin sulfate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polypropylene Sodium chloride 0,9% 0,75 mg/ml
Injection   Bleomycin sulfate   
Injection   Epinephrine hydrochloride 3,5 µg/ml
Injection   Lidocaine hydrochloride 3,5 mg/ml
22°C
1 Day
Not specified 3420
Level of evidence A
Polypropylene Sodium chloride 0,9% 0,75 mg/ml
Injection   Bleomycin sulfate   
Injection   Epinephrine hydrochloride 3,5 µg/ml
Injection   Lidocaine hydrochloride 3,5 mg/ml
4°C
3 Day
Not specified 3420
Level of evidence A
  Mentions Légales